Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Undetectable does not equal untransmittable for HIV and blood transfusion.

Gosbell IB, Hoad VC, Styles CE, Lee J, Seed CR.

Vox Sang. 2019 May 20. doi: 10.1111/vox.12790. [Epub ahead of print] No abstract available.

PMID:
31106848
2.

No evidence for widespread Babesia microti transmission in Australia.

Faddy HM, Rooks KM, Irwin PJ, Viennet E, Paparini A, Seed CR, Stramer SL, Harley RJ, Chan HT, Dennington PM, Flower RLP.

Transfusion. 2019 Jul;59(7):2368-2374. doi: 10.1111/trf.15336. Epub 2019 May 9.

PMID:
31070793
3.

International Forum on Occult hepatitis B infection and transfusion safety.

Seed CR, Allain JP, Lozano M, Laperche S, Gallian P, Gross S, Kwon SY, Oh EY, Kim JN, Chua SS, Lam S, Ang AL, Tsoi WC, Hewitt PE, Davison KL, Tettmar K, O'Flaherty N, Boland F, Williams P, Pomeroy L, Wendel S, Fachini R, Scuracchio P, Carminato P, Fearon M, O'Brien SF, Delage G, Kiely P, Hoad V, Matsubayashi K, Satake M, Taira R, Stramer SL, Sauleda S, Bes M, Piron M, El Ekiaby M, Vermeulen M, Levičnik Stezinar S, Nograšek P, Jarvis LM, Petrik J, Charlewood R, Flanagan P, Grabarczyk P, Kopacz A, Łętowska M, Seifried E, Schmidt M.

Vox Sang. 2019 May;114(4):e1-e35. doi: 10.1111/vox.12743. Epub 2019 Apr 10. No abstract available.

PMID:
30972757
4.

Malaria blood safety policy in five non-endemic countries: a retrospective comparison through the lens of the ABO risk-based decision-making framework.

O'Brien SF, Ward S, Gallian P, Fabra C, Pillonel J, Kitchen AD, Davison K, Seed CR, Delage G, Steele WR, Leiby DA.

Blood Transfus. 2019 Mar;17(2):94-102. doi: 10.2450/2019.0222-18. Epub 2019 Feb 6.

5.

International forum on Occult hepatitis B infection and transfusion safety.

Seed CR, Allain JP, Lozano M, Laperche S, Gallian P, Gross S, Kwon SY, Oh EY, Kim JN, Chua SS, Lam S, Ang AL, Tsoi WC, Hewitt PE, Davison K, Tettmar K, O'Flaherty N, Boland F, Williams P, Pomeroy L, Wendel S, Fachini R, Scuracchio PSP, Carminato P, Fearon M, O'Brien SF, Delages G, Kiely P, Hoad VC, Matsubayashi K, Satake M, Taira R, Stramer SL, Sauleda S, Bes M, Piron M, Ekiaby ME, Vermeulen M, Stezinar SL, Nograšek P, Jarvis LM, Petrik J, Charlewood R, Flanagan P, Grabarczyk P, Kopacz A, Łętowska M, Schmidt M, Seifried E.

Vox Sang. 2019 May;114(4):397-406. doi: 10.1111/vox.12744. Epub 2019 Feb 28. No abstract available.

PMID:
30818422
6.

Modelling the risk of transfusion-transmitted syphilis: a reconsideration of blood donation testing strategies.

Jayawardena T, Hoad V, Styles C, Seed C, Bentley P, Clifford V, Lacey S, Gastrell T.

Vox Sang. 2019 Feb;114(2):107-116. doi: 10.1111/vox.12741. Epub 2018 Dec 18.

PMID:
30565234
7.

Estimation of human T-lymphotropic virus incidence in blood donors from observed prevalence.

Styles CE, Hoad VC, Seed CR.

Vox Sang. 2018 Nov;113(8):814-815. doi: 10.1111/vox.12721. Epub 2018 Oct 14.

PMID:
30318639
8.

Publisher Correction: Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.

Zekavat SM, Ruotsalainen S, Handsaker RE, Alver M, Bloom J, Poterba T, Seed C, Ernst J, Chaffin M, Engreitz J, Peloso GM, Manichaikul A, Yang C, Ryan KA, Fu M, Johnson WC, Tsai M, Budoff M, Vasan RS, Cupples LA, Rotter JI, Rich SS, Post W, Mitchell BD, Correa A, Metspalu A, Wilson JG, Salomaa V, Kellis M, Daly MJ, Neale BM, McCarroll S, Surakka I, Esko T, Ganna A, Ripatti S, Kathiresan S, Natarajan P; NHLBI TOPMed Lipids Working Group.

Nat Commun. 2018 Aug 23;9(1):3493. doi: 10.1038/s41467-018-05975-y.

9.

Deep-coverage whole genome sequences and blood lipids among 16,324 individuals.

Natarajan P, Peloso GM, Zekavat SM, Montasser M, Ganna A, Chaffin M, Khera AV, Zhou W, Bloom JM, Engreitz JM, Ernst J, O'Connell JR, Ruotsalainen SE, Alver M, Manichaikul A, Johnson WC, Perry JA, Poterba T, Seed C, Surakka IL, Esko T, Ripatti S, Salomaa V, Correa A, Vasan RS, Kellis M, Neale BM, Lander ES, Abecasis G, Mitchell B, Rich SS, Wilson JG, Cupples LA, Rotter JI, Willer CJ, Kathiresan S; NHLBI TOPMed Lipids Working Group.

Nat Commun. 2018 Aug 23;9(1):3391. doi: 10.1038/s41467-018-05747-8.

10.

Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.

Zekavat SM, Ruotsalainen S, Handsaker RE, Alver M, Bloom J, Poterba T, Seed C, Ernst J, Chaffin M, Engreitz J, Peloso GM, Manichaikul A, Yang C, Ryan KA, Fu M, Johnson WC, Tsai M, Budoff M, Vasan RS, Cupples LA, Rotter JI, Rich SS, Post W, Mitchell BD, Correa A, Metspalu A, Wilson JG, Salomaa V, Kellis M, Daly MJ, Neale BM, McCarroll S, Surakka I, Esko T, Ganna A, Ripatti S, Kathiresan S, Natarajan P; NHLBI TOPMed Lipids Working Group.

Nat Commun. 2018 Jul 4;9(1):2606. doi: 10.1038/s41467-018-04668-w. Erratum in: Nat Commun. 2018 Aug 23;9(1):3493.

11.

Creutzfeldt-Jakob disease and blood transfusion safety.

Seed CR, Hewitt PE, Dodd RY, Houston F, Cervenakova L.

Vox Sang. 2018 Apr;113(3):220-231. doi: 10.1111/vox.12631. Epub 2018 Jan 22. Review.

PMID:
29359329
12.

Ross River virus in Australian blood donors: possible implications for blood transfusion safety.

Faddy HM, Tran TV, Hoad VC, Seed CR, Viennet E, Chan HT, Harley R, Hewlett E, Hall RA, Bielefeldt-Ohmann H, Flower RLP, Prow NA.

Transfusion. 2018 Feb;58(2):485-492. doi: 10.1111/trf.14472. Epub 2018 Jan 19.

PMID:
29350414
13.
14.

Emerging infectious disease outbreaks: estimating disease risk in Australian blood donors travelling overseas.

Coghlan A, Hoad VC, Seed CR, Flower RL, Harley RJ, Herbert D, Faddy HM.

Vox Sang. 2018 Jan;113(1):21-30. doi: 10.1111/vox.12571. Epub 2017 Oct 19.

PMID:
29052242
15.

Reconsideration of blood donation testing strategy for human T-cell lymphotropic virus in Australia.

Styles CE, Seed CR, Hoad VC, Gaudieri S, Keller AJ.

Vox Sang. 2017 Nov;112(8):723-732. doi: 10.1111/vox.12597. Epub 2017 Sep 27.

PMID:
28960337
16.

Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.

Hoad VC, Seed CR, Fryk JJ, Harley R, Flower RLP, Hogema BM, Kiely P, Faddy HM.

Vox Sang. 2017 Oct;112(7):614-621. doi: 10.1111/vox.12559. Epub 2017 Aug 18.

PMID:
28833229
17.

Erratum to "Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk" (Transfusion Medicine Reviews 31/3 [2017] 154-164).

Kiely P, Gambhir M, Cheng AC, McQuilten ZK, Seed CR, Wood EM.

Transfus Med Rev. 2018 Jan;32(1):66-68. doi: 10.1016/j.tmrv.2017.07.005. Epub 2017 Aug 15. No abstract available.

PMID:
28821369
18.

Re-examining blood donor deferral criteria relating to injecting drug use.

Quinn B, Seed C, Keller A, Maher L, Wilson D, Farrell M, Caris S, Williams J, Madden A, Thompson A, Pink J, Hellard ME.

Int J Drug Policy. 2017 Oct;48:9-17. doi: 10.1016/j.drugpo.2017.05.058. Epub 2017 Jun 27. Review.

PMID:
28666205
19.

Emerging infectious disease agents and blood safety in Australia: spotlight on Zika virus.

Kiely P, Wood EM, Gambhir M, Cheng AC, McQuilten ZK, Seed CR.

Med J Aust. 2017 Jun 5;206(10):455-460. Review.

PMID:
28566073
20.

Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk.

Kiely P, Gambhir M, Cheng AC, McQuilten ZK, Seed CR, Wood EM.

Transfus Med Rev. 2017 Jul;31(3):154-164. doi: 10.1016/j.tmrv.2017.05.002. Epub 2017 May 15. Review. Erratum in: Transfus Med Rev. 2018 Jan;32(1):66-68.

PMID:
28545882
21.

Blood safety implications of donors using HIV pre-exposure prophylaxis.

Seed CR, Yang H, Lee JF.

Vox Sang. 2017 Jul;112(5):473-476. doi: 10.1111/vox.12516. Epub 2017 Mar 31.

PMID:
28370177
22.

Mitigating the Risk of Transfusion-Transmitted Dengue in Australia.

Rooks K, Seed CR, Fryk JJ, Hyland CA, Harley RJ, Holmberg JA, Marks DC, Flower RL, Faddy HM.

J Blood Transfus. 2016;2016:3059848. Epub 2016 Nov 13.

23.

A Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples.

Shrestha AC, Flower RL, Seed CR, Stramer SL, Faddy HM.

J Blood Transfus. 2016;2016:9647675. Epub 2016 Nov 7.

24.

Hepatitis E virus seroepidemiology: a post-earthquake study among blood donors in Nepal.

Shrestha AC, Flower RL, Seed CR, Rajkarnikar M, Shrestha SK, Thapa U, Hoad VC, Faddy HM.

BMC Infect Dis. 2016 Nov 25;16(1):707.

25.

Ultra-rare disruptive and damaging mutations influence educational attainment in the general population.

Ganna A, Genovese G, Howrigan DP, Byrnes A, Kurki M, Zekavat SM, Whelan CW, Kals M, Nivard MG, Bloemendal A, Bloom JM, Goldstein JI, Poterba T, Seed C, Handsaker RE, Natarajan P, Mägi R, Gage D, Robinson EB, Metspalu A, Salomaa V, Suvisaari J, Purcell SM, Sklar P, Kathiresan S, Daly MJ, McCarroll SA, Sullivan PF, Palotie A, Esko T, Hultman C, Neale BM.

Nat Neurosci. 2016 Dec;19(12):1563-1565. doi: 10.1038/nn.4404. Epub 2016 Oct 3.

26.

Hepatitis E virus RNA in Australian blood donations.

Shrestha AC, Flower RL, Seed CR, Keller AJ, Harley R, Chan HT, Hoad V, Warrilow D, Northill J, Holmberg JA, Faddy HM.

Transfusion. 2016 Dec;56(12):3086-3093. doi: 10.1111/trf.13799. Epub 2016 Sep 25.

PMID:
27667133
27.

Flow Cytometric Methods for Indirect Analysis and Quantification of Gametogenesis in Chlamydomonas reinhardtii (Chlorophyceae).

Seed CE, Tomkins JL.

PLoS One. 2016 Sep 27;11(9):e0161453. doi: 10.1371/journal.pone.0161453. eCollection 2016.

28.

Refining the risk estimate for transfusion-transmission of occult hepatitis B virus.

Seed CR, Kiely P, Hoad VC, Keller AJ.

Vox Sang. 2017 Jan;112(1):3-8. doi: 10.1111/vox.12446. Epub 2016 Aug 26.

PMID:
27564651
29.

Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply.

Shrestha AC, Flower RLP, Seed CR, Keller AJ, Hoad V, Harley R, Leader R, Polkinghorne B, Furlong C, Faddy HM.

Blood Transfus. 2017 May;15(3):191-198. doi: 10.2450/2016.0064-16. Epub 2016 Jul 22.

30.

Sorting Motifs in the Cytoplasmic Tail of the Immunomodulatory E3/49K Protein of Species D Adenoviruses Modulate Cell Surface Expression and Ectodomain Shedding.

Windheim M, Höning S, Leppard KN, Butler L, Seed C, Ponnambalam S, Burgert HG.

J Biol Chem. 2016 Mar 25;291(13):6796-812. doi: 10.1074/jbc.M115.684787. Epub 2016 Feb 3.

31.

Re-evaluating the residual risk of transfusion-transmitted Ross River virus infection.

Seed CR, Hoad VC, Faddy HM, Kiely P, Keller AJ, Pink J.

Vox Sang. 2016 May;110(4):317-23. doi: 10.1111/vox.12372. Epub 2016 Jan 8.

PMID:
26748600
32.

Detection of emergent strains of West Nile virus with a blood screening assay.

Faddy HM, Flower RL, Seed CR, Ismay S, Ong E, Linnen JM, Cory R, Holmberg JA, Hall RA, Setoh YX, Deerain JM, Prow NA.

Transfusion. 2016 Jun;56(6 Pt 2):1503-7. doi: 10.1111/trf.13443. Epub 2015 Dec 8.

PMID:
26644018
33.

Hepatitis E.

Petrik J, Lozano M, Seed CR, Faddy HM, Keller AJ, Prado Scuracchio PS, Wendel S, Andonov A, Fearon M, Delage G, Zhang J, Shih JW, Gallian P, Djoudi R, Tiberghien P, Izopet J, Dreier J, Vollmer T, Knabbe C, Aggarwal R, Goel A, Ciccaglione AR, Matsubayashi K, Satake M, Tadokoro K, Jeong SH, Zaaijer HL, Zhiburt E, Chay J, Teo D, Chua SS, Piron M, Sauleda S, Echevarría JM, Dalton H, Stramer SL.

Vox Sang. 2016 Jan;110(1):93-130. doi: 10.1111/vox.12285. Epub 2015 Jul 21. No abstract available.

PMID:
26198159
34.

The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries.

O'Brien SF, Delage G, Seed CR, Pillonel J, Fabra CC, Davison K, Kitchen A, Steele WR, Leiby DA.

Transfus Med Rev. 2015 Jul;29(3):162-71. doi: 10.1016/j.tmrv.2015.03.004. Epub 2015 Mar 26. Review.

PMID:
25933591
35.

The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components.

Seed CR, Wong J, Polizzotto MN, Faddy H, Keller AJ, Pink J.

Vox Sang. 2015 Jul;109(1):11-7. doi: 10.1111/vox.12250. Epub 2015 Apr 8.

PMID:
25854287
36.

First reported case of transfusion-transmitted Ross River virus infection.

Hoad VC, Speers DJ, Keller AJ, Dowse GK, Seed CR, Lindsay MD, Faddy HM, Pink J.

Med J Aust. 2015 Mar 16;202(5):267-70. No abstract available.

PMID:
25758699
37.

Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history?

Shrestha AC, Faddy HM, Flower RL, Seed CR, Keller AJ.

Pathology. 2015 Feb;47(2):97-100. doi: 10.1097/PAT.0000000000000229. Review.

38.

Seroprevalence of Antibodies to Ross River and Barmah Forest Viruses: Possible Implications for Blood Transfusion Safety After Extreme Weather Events.

Faddy H, Dunford M, Seed C, Olds A, Harley D, Dean M, Racloz V, McCarthy S, Smith D, Flower R.

Ecohealth. 2015 Jun;12(2):347-53. doi: 10.1007/s10393-014-1005-0. Epub 2014 Dec 24.

PMID:
25537629
39.

Hepatitis E virus and implications for blood supply safety, Australia.

Shrestha AC, Seed CR, Flower RL, Rooks KM, Keller AJ, Harley RJ, Chan HT, Holmberg JA, Faddy HM.

Emerg Infect Dis. 2014 Nov;20(11):1940-2. doi: 10.3201/eid2011.140412. No abstract available.

40.

Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme.

Seed CR, Maloney R, Kiely P, Bell B, Keller AJ, Pink J; Blood Service Medical Services Lookback Team.

Vox Sang. 2015 Feb;108(2):113-22. doi: 10.1111/vox.12198. Epub 2014 Sep 19.

PMID:
25234417
41.

Antibodies to Leptospira among blood donors in higher-risk areas of Australia: possible implications for transfusion safety.

Faddy H, Seed C, Lau C, Racloz V, Flower R, Smythe L, Burns MA, Dohnt M, Craig S, Harley R, Weinstein P.

Blood Transfus. 2015 Jan;13(1):32-6. doi: 10.2450/2014.0012-14. Epub 2014 Jun 19.

42.

A refined method for estimating the size of the potential blood donor pool in Australia.

Lucky TT, Keller AJ, Seed CR, Lee J, Styles C, Pink J, Wilson DP.

Transfusion. 2014 Oct;54(10):2445-55. doi: 10.1111/trf.12649. Epub 2014 May 4.

PMID:
24796704
43.

Understanding noncompliance with selective donor deferral criteria for high-risk behaviors in Australian blood donors.

Lucky TT, Seed CR, Waller D, Lee JF, McDonald A, Wand H, Wroth S, Shuttleworth G, Keller AJ, Pink J, Wilson DP.

Transfusion. 2014 Jul;54(7):1739-49. doi: 10.1111/trf.12554. Epub 2014 Apr 10.

PMID:
24720444
44.

Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.

Kiely P, Margaritis AR, Seed CR, Yang H; Australian Red Cross Blood Service NAT Study Group.

Transfusion. 2014 Aug;54(8):2084-91. doi: 10.1111/trf.12556. Epub 2014 Mar 20.

PMID:
24650170
45.

Compliance with the current 12-month deferral for male-to-male sex in Australia.

Seed CR, Lucky TT, Waller D, Wand H, Lee JF, Wroth S, McDonald A, Pink J, Wilson DP, Keller AJ.

Vox Sang. 2014 Jan;106(1):14-22. doi: 10.1111/vox.12093. Epub 2013 Oct 10. Erratum in: Vox Sang. 2014 Apr;106(3):284.

PMID:
24117918
47.

Implications of dengue outbreaks for blood supply, Australia.

Faddy HM, Seed CR, Fryk JJ, Hyland CA, Ritchie SA, Taylor CT, Van Der Merwe KL, Flower RL, McBride WJ.

Emerg Infect Dis. 2013 May;19(5):787-9. doi: 10.3201/eid1905.121664.

48.

Trends in transfusion-transmissible infections among Australian blood donors from 2005 to 2010.

Lucky TT, Seed CR, Keller A, Lee J, McDonald A, Ismay S, Wand H, Wilson DP.

Transfusion. 2013 Nov;53(11):2751-62. doi: 10.1111/trf.12144. Epub 2013 Mar 5.

PMID:
23461827
49.

Malaria antibody persistence correlates with duration of exposure.

Faddy HM, Seed CR, Faddy MJ, Flower RL, Harley RJ.

Vox Sang. 2013 May;104(4):292-8. doi: 10.1111/vox.12000. Epub 2012 Nov 8.

PMID:
23134513
50.

Two cases of asymptomatic HBV "vaccine breakthrough" infection detected in blood donors screened for HBV DNA.

Seed CR, Jones NT, Pickworth AM, Graham WR.

Med J Aust. 2012 Jun 4;196(10):651-2. No abstract available.

PMID:
22676882

Supplemental Content

Support Center